Thalassemia

3 December 2025

What Is Thalassemia?

Thalassemia is a genetic blood disorder in which the body is unable to produce enough healthy hemoglobin.
  Hemoglobin is the protein that carries oxygen to all parts of the body.

When hemoglobin production is low or abnormal:

  • The body makes fewer red blood cells
  • The red blood cells break down early
  • Oxygen delivery to tissues decreases

This leads to anemia (low hemoglobin), which can cause fatigue, weakness, and many other symptoms.

Why Does Thalassemia Happen?

Thalassemia occurs because of a change in the genes responsible for making hemoglobin. These gene changes are inherited.

How It Is Inherited (Passed On)

Every person gets one set of hemoglobin genes from each parent.
  Depending on how many genes are affected, thalassemia can be mild, moderate, or severe.

  • If one parent passes a faulty gene:
     The child becomes a carrier (called Thalassemia Minor). Usually, there are no major symptoms.
  • If both parents pass faulty genes:
     The child may develop Thalassemia Major or Intermedia, which are more severe.

Thalassemia is not caused by diet, lifestyle, or infection. It is purely genetic.

Types of Thalassemia

  1. Alpha Thalassemia

Occurs when the alpha part of hemoglobin is affected.

  1. Beta Thalassemia

Occurs when the beta part of hemoglobin is affected.
  (This is the most common type in India.)

Beta Thalassemia is further classified into:

  • Thalassemia Minor (Trait):
     Mild, usually no symptoms. Often discovered during routine tests.
  • Thalassemia Intermedia:
     Moderate anemia, may require occasional medical care.
  • Thalassemia Major:
    Severe anemia appearing in the first year of life. Requires regular treatment.

What Are the Symptoms of Thalassemia?

Symptoms depend on the type:

Thalassemia Minor (Trait)

  • Usually no symptoms
  • Mild anemia may occur

Thalassemia Intermedia/Major

  • Severe anemia
  • Tiredness and weakness
  • Pale skin
  • Disturbed growth in children
  • Frequent infections
  • Enlarged spleen or liver

How Is Thalassemia Diagnosed?

Doctors use several tests:

  1. Complete Blood Count (CBC)

Shows anemia and small-sized red blood cells.

  1. Hemoglobin Electrophoresis / HPLC

Confirms the type of thalassemia by measuring different hemoglobin levels.

  1. Genetic Testing

Detects specific gene changes, useful for family planning and early diagnosis.

  1. Prenatal Testing

Helps detect thalassemia in the baby during pregnancy.

How Is Thalassemia Treated?

Treatment depends on the severity.

  1. Regular Blood Transfusions
    Used mainly for Thalassemia Major. They help maintain normal hemoglobin levels so the body gets enough oxygen.
  1. Iron Chelation Therapy
    Repeated transfusions cause extra iron to build up in the body. This can damage organs like the heart and liver. Chelation therapy uses special medicines to remove excess iron.
  1. Folic Acid Supplements
    Helps the body make red blood cells.
  1. Managing Enlarged Spleen
    Sometimes the spleen becomes too large and removes blood cells too quickly. Doctors may recommend treatment or surgery if needed.
  1. Bone Marrow / Stem Cell Transplant
    This is the only potential cure for thalassemia in selected patients. It replaces the faulty bone marrow with healthy donor cells.
  1. Emerging Therapies Research is advancing rapidly:
  • Gene therapy (corrects the faulty gene)
  • Gene editing like CRISPR
  • Newer medications to improve hemoglobin production

Conclusion

Thalassemia is a genetic condition that affects the body’s ability to make hemoglobin, but it is highly manageable with modern medical care. Early diagnosis, personalised treatment, and regular monitoring can help patients lead healthy lives. Although it is a lifelong condition, medical advances have made it far more manageable today. Early diagnosis and proper treatment can help patients live healthy and fulfilling lives.

- Medically reviewed by Dr. Amit Jain (Consultant, Pediatric Hematology-Oncology & Bone Marrow Transplant)

Facebook
Twitter
LinkedIn
Email
SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct head and neck cancer case study using TCR-p53 therapy in inoperable squamous cell carcinoma
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male